Contract Modification for BioThrax Product Supply under Contract #200-2011-42084

Summary

This contract modification involves the supply of BioThrax product doses between the supplier and the buyer, as part of contract #200-2011-42084. The modification adjusts the funded amount and quantity for a specific line item, updates the delivery schedule, and allows for an option to purchase additional doses. The contract outlines the revised delivery periods and total contract value, while all other terms remain unchanged.

EX-10.4 8 exhibit10-4.htm
Exhibit 10.4
 
Confidential Materials omitted and filed separately with the
Securities and Exchange Commission. Double asterisks denote omissions.
 
 

 


 
SECTION B – SUPPLIES OR SERVICES AND PRICES/COSTS
ITEM
SUPPLIES/SERVICES
QTY/UNIT
UNIT
PRICE
EXTENDED PRICE
0002-02
BioThrax [**] product
BioThrax [**] product
[**] upon date of delivery [**]
 
Corresponds to Line Item 0002B in contract.
 
To be delivered in accordance with the delivery schedule below
[**] Doses
$[**]
$[**]
 
Line(s) Of Accounting: 939ZTGA 2642 2012 75-X-0956 ###-###-#### $[**]
 
 
 
Option 1 Option for Additional Items:
ITEM
SUPPLIES/SERVICES
QTY/UNIT
UNIT
PRICE
EXTENDED PRICE
0002-02
BioThrax [**] product
BioThrax [**] product
[**] upon date of delivery [**]
 
To be delivered in accordance with the delivery schedule below
[**] Doses
$[**]
$[**]
 
Line(s) Of Accounting: 939ZTGA 2642 2012 75-X-0956 ###-###-#### [**]
 
 
 
The purpose of this modification is to transfer funds between CLINS, modify the product doses as described and incorporate these in scope changes to contract #200-2011-42084.
A.
The contract funded amount for CLIN 0002 is decreased by $[**] from $[**] to $[**]. CLIN0002 is reduced in quantity from [**] product doses to [**] product doses.
As a result:
1.
CLIN 0002- 02 is is funded in the amount of $[**] for [**] product doses.
2.
Section C.2 Delivery Schedule and section F.3.1 are revised as follows:


 


Product
 
CLIN
Price per
Dose
Doses
$
Delivery Period
0001
[**]
[**]
[**]
October 1, 2011 to December 31, 2012
0002
[**]
[**]
[**]
January 1, 2013 to November 30, 2013
0002-02
[**]
[**]
[**]
January 1, 2013 to November 30, 2014
0003
[**]
[**]
[**]
December 1, 2013 to November 30, 2014
0004
[**]
[**]
[**]
December 1, 2014 to October 31, 2015
0005
[**]
[**]
[**]
November 1, 2015 to September 30, 2016
Total
 
44,750,000
$1,234,775,641.30
 

Consider all other terms and conditions of the contract unchanged and in full force and effect.